Capturing the GLP-1 Consumer: Formulating for During, After and Beyond
GLP-1s are no longer a niche category. They are creating a multi-stage nutrition journey that intrigues a variety of consumers. Approximately 18% of U.S. consumers are estimated to either currently take or have taken a GLP-1 drug, with an additional 16% reporting interest.1 For brands looking to be competitive in this market, innovation means looking beyond a single use case.
